https://www.indianpharmapost.com/astrazenecas-flaura2-phase-iii-trial-showed-favourable-trend-in-egfr-mutated-advanced-lung-cancer-154302024-03-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/briefs-concord-biotech-and-neuland-laboratories-154312024-03-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/sharon-bio-medicine-resumes-operations-154322024-03-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/illness-to-wellness-joins-hands-with-ilbs-to-generate-awareness-against-hepatitis-b-patients-154332024-03-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-grants-odd-to-cevidoplenib-for-immune-thrombocytopenia-154342024-03-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-and-pharmazz-inks-agreement-to-market-centhaquine-for-hypovolemic-shock-in-india-154352024-03-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-tentative-approval-from-usfda-for-letermovir-tablets-154362024-03-23T00:00:00+05:30always0.9